Tim M. Mayleben

2019 - Esperion Therapeutics

In 2019, Tim M. Mayleben earned a total compensation of $1.1M as President and Chief Executive Officer at Esperion Therapeutics, a 89% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$375,000
Salary$625,000
Other$80,850
Total$1,080,850

Mayleben received $625K in salary, accounting for 58% of the total pay in 2019.

Mayleben also received $375K in non-equity incentive plan and $80.9K in other compensation.

Rankings

In 2019, Tim M. Mayleben's compensation ranked 8,935th out of 13,971 executives tracked by ExecPay. In other words, Mayleben earned more than 36.0% of executives.

ClassificationRankingPercentile
All
8,935
out of 13,971
36th
Division
Manufacturing
3,577
out of 5,701
37th
Major group
Chemicals And Allied Products
1,352
out of 2,200
39th
Industry group
Drugs
1,153
out of 1,886
39th
Industry
Pharmaceutical Preparations
854
out of 1,398
39th

Pay ratio

Tim M. Mayleben's Pay$1,080,850
Median Employee's Pay$242,988
Pay Ratio

4

to 1

In 2019, the annual total compensation of Tim M. Mayleben was $1,080,850.

The annual total compensation of the median employee at Esperion Therapeutics was $242,988.

The ratio of Tim M. Mayleben's pay to the pay of median employee was therefore 4 to one.

Source: SEC filing on April 16, 2020.

Mayleben's colleagues

We found two more compensation records of executives who worked with Tim M. Mayleben at Esperion Therapeutics in 2019.

2019

Mark Glickman

Esperion Therapeutics

Chief Commercial Officer

2019

Richard Bartram

Esperion Therapeutics

Chief Financial Officer

News

You may also like